Capital Flow Monitor · Sponsors · CIK 1792694
Affinia Therapeutics Inc.
43 FOUNDRY AVE, SUITE 120, WALTHAM, MA, 02453 · 617-430-7817
Other · Corporation· inc. DELAWARE true
Fit score
—
Offering
$45.0M
Sold
$13.3M
% sold
29.5%
Investors
20
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-14 | D ·current | 506(b) | $45.0M | $13.3M | 29.5% | 20 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Rick Modi — Executive Officer / Director, WALTHAM, MA
- Rami Daoud — Executive Officer, WALTHAM, MA
- Sean Nolan — Director, WALTHAM, MA
- Diana Brainard — Director, WALTHAM, MA
- Elliott Sigal — Director, WALTHAM, MA
-
Edward Mathers — Director, WALTHAM, MA
1 other raise
- Senti Biosciences Holdings, Inc. $10.0M of $40.0M · 25.0%
-
David Grayzel — Director, WALTHAM, MA
1 other raise
- Triana Biomedicines, Inc. $120.1M of $120.1M · 100.0%
- Carole Faig — Director, WALTHAM, MA
- Luc Vandenberghe — Director, WALTHAM, MA
-
Robert Weisskoff — Director, WALTHAM, MA
1 other raise
- Adela, Inc. $25.4M of $27.0M · 94.2%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.